Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Cekanova

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Drug Design, Development and Therapy|October 10, 2015
A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitroKusum Rathore, Maria Cekanova
Drug Design, Development and Therapy|October 25, 2014
Animal models and therapeutic molecular targets of cancer: utility and limitationsMaria Cekanova, Kusum Rathore
BMC Cancer|June 27, 2014
Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell linesKusum Rathore, Maria Cekanova
Drug Design, Development and Therapy|June 27, 2018
Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitroJennifer Bourn, Maria Cekanova
Research in Veterinary Science|December 19, 2015
Effects of environmental carcinogen benzo(a)pyrene on canine adipose-derived mesenchymal stem cellsKusum Rathore, Maria Cekanova
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathwaysHildegard M Schuller, Maria Cekanova
Oncotarget|July 10, 2018
Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cellsSony Pandey, Jennifer Bourn, Maria Cekanova
Translational Research : the Journal of Laboratory and Clinical Medicine|March 18, 2014
Piroxicam inhibits Masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitroKusum Rathore, Mary Alexander, Maria Cekanova
Drug Design, Development and Therapy|October 28, 2016
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerDmitriy Smolensky, Kusum Rathore, Maria Cekanova
BMC Cancer|November 25, 2015
Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitroDmitriy Smolensky, Kusum Rathore, Maria Cekanova
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Drug Design, Development and Therapy|October 10, 2015
A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitroKusum Rathore, Maria Cekanova
Drug Design, Development and Therapy|October 25, 2014
Animal models and therapeutic molecular targets of cancer: utility and limitationsMaria Cekanova, Kusum Rathore
BMC Cancer|June 27, 2014
Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell linesKusum Rathore, Maria Cekanova
Drug Design, Development and Therapy|June 27, 2018
Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitroJennifer Bourn, Maria Cekanova
Research in Veterinary Science|December 19, 2015
Effects of environmental carcinogen benzo(a)pyrene on canine adipose-derived mesenchymal stem cellsKusum Rathore, Maria Cekanova
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathwaysHildegard M Schuller, Maria Cekanova
Oncotarget|July 10, 2018
Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cellsSony Pandey, Jennifer Bourn, Maria Cekanova
Translational Research : the Journal of Laboratory and Clinical Medicine|March 18, 2014
Piroxicam inhibits Masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitroKusum Rathore, Mary Alexander, Maria Cekanova
Drug Design, Development and Therapy|October 28, 2016
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerDmitriy Smolensky, Kusum Rathore, Maria Cekanova
BMC Cancer|November 25, 2015
Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitroDmitriy Smolensky, Kusum Rathore, Maria Cekanova
Pageof 5